SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Zeev's Turnips - No Politics -- Ignore unavailable to you. Want to Upgrade?

To: lh56 who wrote (733)10/17/2001 11:10:45 PM
From: lh56  Respond to of 99280
 
anyone follow tlab? from briefing.com analysis 10/16:

"... Aggressive estimate cuts this late in the cycle have historically provided an opportunity for telecom equipment companies to begin delivering upside to projections. Unfortunately, the sector is also notorious for its false starts. Until we hear directly from telecom service providers of no further plans to significantly cut capital expenditures, we think that TLAB's will remain a laggard stock. From a valuation standpoint, we see downside risk in the name into the $6-$7 area, at which time we would begin accumulating TLAB as a core holding in advance of the next telecom buildout. - Damon Southward, Briefing.com"

thanks,
larry



To: lh56 who wrote (733)10/18/2001 8:55:29 AM
From: Zeev Hed  Read Replies (3) | Respond to of 99280
 
I would say more like the $50/$55 area. But for the bio Q, I amreally expecting a break of the upper range.

Zeev


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News